Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Xingrui Biotechnology is a chemical manufacturing enterprise based in Heze, Shandong Province, China, specializing in the production of pharmaceutical intermediates and food additives. The company is a significant global producer of sweeteners, most notably sodium saccharin, and related chemical precursors such as o-toluene sulfonamide and p-toluene sulfonamide. It operates large-scale manufacturing facilities designed to supply the global food, beverage, and pharmaceutical sectors with high-purity chemical components. Xingrui Biotechnology focuses on industrial-scale synthesis, quality-assured production, and maintaining international standards for fine chemicals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Xingrui Biotechnology.